Greg Curt died last Sunday. For us in oncology, this one was especially personal. He was a wonderful, generous young man. Greg was a beloved friend and colleague. He was an accomplished cancer researcher and leader in oncology who died of the disease we treat.
The standard obituary reads that he was born in 1952 in Fall River, Mass. He graduated from Providence College and the University of Rochester School of Medicine. He did residency at New England Deaconess Hospital and a fellowship in medical oncology at the NCI.
Greg was a medical oncologist, a cancer researcher. He rose to become head of the clinical oncology program and clinical director of the NCI. After retiring from the U.S. Public Health Service with the rank of captain, Greg went to work for AstraZeneca. There he forged partnerships with the NCI for the further development of new cancer drugs. He served on the CEO Roundtable on Cancer, the National Cancer Policy Board and in a number of other influential positions.
This is an excerpt of an article that was published in full in The Cancer Letter.
